Each month, the International Foundation’s three resident benefits nerdthusiasts Julie Stich, Kelli Kolsrud and Justin Held, meet to discuss the top stories in retirement and health care, the latest benefits hot topics, and take a deeper dive into a trending benefits topic. This month, the team tackles specialty drugs and what plan sponsors can do to help control costs while supporting participants in need of such treatments. But first, a quick news update:

DOL’s Fiduciary/Conflict of Interest Rule
As mentioned in the previous podcast, a three-judge panel of the 5th Circuit Court of Appeals decided against the rule. This month, Julie summarizes the current status of the rule and what the Securities and Exchange Commission (SEC) has up their sleeves.

Trump Administration Blueprint to Lower Prescription Drug Costs
Kelli explains that earlier in May, the Trump administration released a plan to lower the cost of prescription drugs with goals like increasing competition and reducing out-of-pocket spending for patients. Another idea is to require drug companies to disclose the list prices of drugs in TV ads.

Specialty Prescription Drugs
Expanding on the topic of drug costs and transparency, the podcast team takes a deep dive into the complicated and costly world of specialty drugs. The retail price of specialty drugs increased by almost 10% in 2015, following nine years of increases. While specialty drug prescriptions will be issued to only 1% to 2% of participants on average, their cost can account for one third to half of the entire prescription drug spend.

Discover why specialty drugs are priced so high, the science behind the drugs, and what plan sponsors can do to control costs. After you take a listen, e-mail podcast@ifebp.org if you have any specialty drug-related stories of your own to share.

Anne Patterson

Communications Associate at the International Foundation

Favorite Foundation service/product: The innovative member survey efforts and results from the research team.

Benefits-related topics that interest her most: Health care, nontraditional wellness initiatives, employee benefit communication.

Personal Insight: It’s all about balance with Anne. She loves to run and enjoys a good culinary adventure. She’ll jump at the chance to travel or to spend fun times with family and friends, but she’ll also take time to catch her breath with an occasional Netflix binge or diving into a classic novel.

1 Comment

  1. Michelle A Mills

    Great information, I will be giving some of these recommendations to my leadership team.

Comments are closed.

Recommended Posts

New Mental Health Parity Guidance: More Clarity, But More Compliance Obligations

Anne Newhouse

According to speaker John Barlament, Shareholder, Reinhart Boerner Van Deuren, S.C., in his webcast “New Mental Health Parity Guidance: More Clarity, But More Compliance Obligations,” held on August 30, 2023, new guidance has been “desperately needed” on the topic of mental health […]

Legal & Legislative Reporter: Medical Provider May Not Bring Claim on Behalf of Participants and Beneficiaries

Guest Contributor

Every month, the International Foundation releases the Legal and Legislative Reporter, a compilation of new employee benefits–related case summaries. Below is a summary we thought you’d be interested in. Content provided by Morgan, Lewis & Bockius LLP. The U.S. District Court for the […]

Five Steps to Nurture Belonging in the Workplace

Guest Contributor

Benefits Magazine Extras articles provide you with bonus content on a mix of benefits topics as well as deep dives and analyses on the latest benefit trends and compliance issues. Visit ifebp.org/benefitsmagazine to see the latest Benefits Magazine Extras as well as the bimonthly print […]